-+ 0.00%
-+ 0.00%
-+ 0.00%

Exosens raises FY 2026 revenue outlook to EUR 558 million-EUR 570 million

PUBT·09/17/2026 05:15:24
Listen to the news
Exosens raises FY 2026 revenue outlook to EUR 558 million-EUR 570 million
  • Exosens raised fiscal 2026 guidance on faster-than-expected European production ramp-up, strong commercial momentum, rising nuclear instrumentation demand.
  • Revenue forecast lifted to EUR 558 million-EUR 570 million from EUR 520 million-EUR 540 million, implying about 20% growth vs 2025.
  • Adjusted EBITDA outlook increased to EUR 186 million-EUR 192 million from EUR 168 million-EUR 178 million, implying about 25% growth vs 2025.
  • Capital expenditure still seen at about 9% of revenue, excluding capitalized R&D spending of about 3% of revenue.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Exosens SA published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609170115OMX_____CNEWS_FR_GNW1001263137_fr) on September 17, 2026, and is solely responsible for the information contained therein.